Pediatrics

Open, randomized, adaptive, phase III clinical trial study to evaluate the efficacy of various pharmacological alternatives in the treatment of severe infection in COVID-19 pediatric patients.

Which is the COVID-19 onset and severity? We study the role of the nasopharyngeal microbiota and the host ACE2 receptor in the pediatric and adult population to have an answer.

This COVID-19 study defines the immunological and biochemical biomarkers in pediatric patients, and compares it with other population groups.

How do children transmit SARS-CoV-2? This COVID-19 study aims to answer this question by analyzing pediatric age cases in school like environments.

How do host’s genetics influence the susceptibility and severity of the infection? Find out more in GEN-COVID, a COVID-19 study about genetics.

A national register to study how COVID-19 behaves in the pediatric population, its impact on the global epidemic, and its consequences on the child and youth population.

This study allows in-depth understanding of the transmission of the infection, as well as the immune response that occurs in pregnant mothers and the newborn population during COVID-19.

A COVID-19 study for determining the SARS-CoV-2 seroconversion rate in the postoperative clinical course of the pediatric population.

Are children less susceptible than adults to COVID-19? A COVID-19 study to pediatric population exposed to SARS-CoV-2 and their household contacts.

Study based on observing the differences in symptomatology between positive and negative children participating in Osona, and what seasonal patterns the virus follows.